BioQingLam is a high-tech enterprise specializing in soluble microcrystal transdermal delivery technology. We are committed to revolutionizing traditional drug delivery methods and are poised to achieve the world's first industrial application of soluble microcrystal transdermal technology.
We have built a professional microcrystal formulation development team that has successfully resolved key indicators of soluble microcrystal technology, including active ingredient loading capacity, bioavailability, and content uniformity. We embrace a delivery result-oriented mindset in technology development. Our various microcrystal formulation samples have successively undergone in vivo microcrystal-head transdermal delivery studies across multiple animal species — rats, dogs, pigs, and monkeys — and ultimately progressed to human studies, achieving transdermal delivery results that comply with regulatory requirements. We have established small-scale and pilot-scale laboratories in Shenzhen, along with R&D and production quality management systems, providing a robust technical and compliance foundation for the transdermal delivery development of various products.
We have also assembled teams for soluble microcrystal product production, quality management, and industrialization. In the Greater Bay Area, we have designed and constructed the world's first commercial soluble microcrystal production line — which is also the world's first aseptic-process soluble microcrystal production line. We have independently designed and developed the complete set of soluble microcrystal process and production equipment, with a batch capacity of up to 200,000 patches per batch per day. The production line is designed in full compliance with GMP requirements of China, the United States, and Europe, supporting drug R&D and commercial registration applications across all regulatory jurisdictions worldwide.
We hold proprietary intellectual property rights covering the full spectrum of soluble microcrystal technology — from formulations and processes to equipment and quality standards — and have systematically filed international intellectual property registrations.